Lokavant Introduces First Source-Agnostic Data Engine to Drive Better Clinical Trial Decision-Making and Improve Performance
Lokavant , the clinical trial intelligence platform company, announces PRIZM™ Clinical Data Hub (CDH), the industry’s source-agnostic clinical data hub to aid decision-making and improve trial performance with predictive analytics.
- Lokavant , the clinical trial intelligence platform company, announces PRIZM™ Clinical Data Hub (CDH), the industry’s source-agnostic clinical data hub to aid decision-making and improve trial performance with predictive analytics.
- The life sciences industry struggles to harness enough data to fuel AI for practical uses in clinical research.
- All trial data is harmonized in PRIZM which fuels Lokavant’s platform to provide a centralized view of trial performance in real time.
- The industry needs a reliable solution to distill and standardize all the various data sources to drive improved clinical trial decisions.